Kenyans eligible for the injectable HIV Pre-Exposure Prophylaxis (PrEP) will receive at least four jabs in a year.
The long-acting injection, Lenacapavir, is administered twice a year, once every six months, but during the first visit, a client receives two injections to complete the initial dose.
Individuals qualified for the jab shall be required to take oral PrEP tablets during initiation of the first jab to ensure rapid protection against HIV disease.
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.